Simo Arredouani

[Florian Muller @FlorianPwdrGate]

The Lindonlight Collective's RFA is now out!

Projects focusing on pediatric low grade glioma covering diverse approaches - therapeutics development to basic cancer biology.

https://t.co/xCahf1fziJ

[Lindonlight Collective @Lindonlight]

The Lindonlight Collective RFA is out. Looking for high impact translational proposals focused on pediatric low grade glioma. Applications due September 1st!

[Simo Arredouani @SimoArredouani]

Great funding opportunity to find a cure for pediatric brain cancer. #lindonlightcollective #pLGG

[Nataliya Prokhnevska🇺🇦 @nataliya_pro_]

If you want to hear about T cells in tumors and what I’ve been doing for the last couple years, tomorrow is your day! Watch @HaydnKissick talk for the cancer immunology program @WinshipAtEmory

[Intellia Therapeutics @intelliatx]

Today, Intellia announced that the first patient has been treated with NTLA-2001, which we are developing as a potential single-course, curative therapy for all forms of #ATTR using #CRISPR /Cas9. Full press release here: https://t.co/Xc7gdW2nHo #transthyretinamyloidosis

[Intellia Therapeutics @intelliatx]

Today, $NTLA announced Q3 2020 financial results and that we remain on track to dose the first patient with NTLA-2001 for the treatment of #ATTR using #CRISPR /Cas9 by the end of the year. Full press release here: https://t.co/3ruEn86Ivh #genomeediting

[Intellia Therapeutics @intelliatx]

Intellia recently gathered virtually to host its Fourth Annual Symposium, a company tradition where our co-founders join us for the day and employees present their work. We asked our CSO @LauraSeppLore a few questions about what this event means to her. #CRISPR #IamIntellia

[Prostate Cancer Foundation @PCFnews]

Always standing for men's health. #PCF #CuringTogether

[Cell Therapy News @celltherapynews]

🧬 @GeneTherapy_SN review!

Gene correction using #CRISPR-Cas9 is an extension of #GeneTherapy that has received considerable attention in recent years and boasts many possible uses beyond classical gene therapy approaches. @IIHG_Genetics

https://t.co/BX59I1BOYW

[Intellia Therapeutics @intelliatx]

We’re pleased to announced that $NTLA received authorization of its Clinical Trial Application by @MHRAgovuk to initiate a global Phase 1 clinical trial of NTLA-2001 for the treatment of #ATTR. Full press release here: https://t.co/A1Cl9gBPLB #genomeediting

[Simo Arredouani @SimoArredouani]

We did it!

[Intellia Therapeutics @intelliatx]

We’re pleased to announced that $NTLA received authorization of its Clinical Trial Application by @MHRAgovuk to initiate a global Phase 1 clinical trial of NTLA-2001 for the treatment of #ATTR. Full press release here: https://t.co/A1Cl9gBPLB #genomeediting

[Intellia Therapeutics @intelliatx]

Congratulations to Intellia co-founder Jennifer Doudna and Emmanuelle Charpentier for winning the 2020 #NobelPrize in Chemistry! #CRISPR #genomeediting #RoadtotheClinic

[Intellia Therapeutics @intelliatx]

Welcome to @amicusrx1 CEO and @GlobalGenes Chairman John Crowley to Intellia’s Board of Directors! He is a leader in advancing therapies for people living with rare diseases and we look forward to his strategic guidance as we enter the clinic this year. https://t.co/FNgtN8FqFr

[Intellia Therapeutics @intelliatx]

As we continue to develop therapies for severe and life-threatening diseases, we remain dedicated to championing a culture that celebrates diversity and fosters collaboration. Check out some of our 2019 team photos: https://t.co/DhW4qbBFMy #OneIntellia #CRISPR

[Intellia Therapeutics @intelliatx]

We’ve got new preclinical data showing persistent in vivo editing and durability using our in vivo #CRISPR/ Cas9 technology at this week’s Annual @OTSociety Meeting. Tune into Intellia Sr. Director Tony Forget’s presentation today. https://t.co/hIjopNxSmo

[Intellia Therapeutics @intelliatx]

Intellia is a proud sponsor of this year’s @OTSociety Annual Meeting! We are looking forward to the presentations and scientific exchange happening virtually. View the agenda: https://t.co/yNQvQe2ZWk #CRISPR #genomeediting

[Intellia Therapeutics @intelliatx]

Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference https://t.co/ohXrqzqAfm $NTLA #CRISPR #genomeediting

[Stad Leuven @stadleuven]

Leuven, wij zijn Europese Hoofdstad van Innovatie. En daar hebben we met z'n allen samen voor gezorgd! #WijZijnLeuven

[Mohamed Ridouani @MohamedRidouani]

I'm so proud that Leuven has been elected European Capital of Innovation and wins 1 million euros for the way in which we innovate and work together to improve the quality of life in our city, with and for everyone. #iCapitalAwards

[Mohamed Ridouani @MohamedRidouani]

Ontzettend trots dat Leuven verkozen is tot European Capital of Innovation, voor de manier waarop we vernieuwen en samenwerken om het leven in onze stad te verbeteren met én voor iedereen. We did it! #iCapitalAwards #RIdaysEU